Andrés Caicedo
- Ph.D. in Medical Biology, specialization in Cell Interaction, University of Montpellier, France.
- Master BioMed, specialization Control of Cell Determinism, University of Montpellier, France.
- University Diploma in Management, University of Montpellier.
- Degree in Biology, Pontificia Universidad Católica del Ecuador in Quito.
Dr. Andrés Caicedo is a distinguished scientist in the field of Biomedicine, having earned his Ph.D. with honors in 2013 from the University of Montpellier, where he also completed specializations in Regenerative Medicine and Management. As a Professor-Researcher at the School of Medicine of the San Francisco University of Quito since 2016, Dr. Caicedo spearheads the Biomedical Discovery Team and the Dragon BioMed Initiative, demonstrating a commitment to innovation in advanced cell-based therapies and biomarker application.
His notable contributions to the field were internationally recognized when he was selected as an Innovator Under 35 in Latin America by MIT Tech Review in 2017, specifically for his groundbreaking study, "MitoCeption." This accolade was complemented by his victory in the 2017 Innovation Call “Ecuador Changes the World” for AEI, further underscoring his influence on biomedical research.
Dr. Caicedo has a prolific portfolio of scientific publications and patents, underscoring his expertise and ongoing quest for novel therapeutic agents. In 2023, his leadership and vision were further endorsed as he was elected Vice President of the International Society for Cell & Gene Therapy (ISCT) for the South and Central American region and honored with the organization’s prestigious Trailblazer award. Dr. Caicedo's career is marked by a relentless pursuit of excellence and a passion for positioning USFQ as a vanguard institution in regenerative medicine.